Stock Comparison
Abbott Laboratories vs Roche Holding AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Abbott Laboratories
ABT · New York Stock Exchange
Weighted across the company's segments.
Full stock profile
Dive deeper into Abbott Laboratories's moat claims, evidence, and risks.
View ABT analysisRoche Holding AG
ROP · SIX Swiss Exchange (participation certificate)
Weighted across the company's segments.
Full stock profile
Dive deeper into Roche Holding AG's moat claims, evidence, and risks.
View ROP analysisComparison highlights
- Moat score gap: Roche Holding AG leads (69 / 100 vs 22 / 100 for Abbott Laboratories).
- Segment focus: Abbott Laboratories has 9 segments (27% in Cardiovascular and Electrophysiology Devices); Roche Holding AG has 2 segments (77.8% in Pharmaceuticals).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: Abbott Laboratories has 1 moat types across 1 domains; Roche Holding AG has 3 across 2.
Primary market context
Abbott Laboratories
Cardiovascular and Electrophysiology Devices
Rhythm management, electrophysiology, heart failure, vascular and structural-heart devices
Global
Hospitals, ambulatory surgery centers and cardiovascular clinicians
Implantable and procedure-based device manufacturer
27%
Roche Holding AG
Pharmaceuticals
Innovative (branded) prescription pharmaceuticals
Global
Healthcare providers and systems (hospitals/clinics), payers/governments, and patients
Innovator pharmaceutical developer, manufacturer and marketer
77.8%
Side-by-side metrics
Moat coverage
Shared moat types
Abbott Laboratories strengths
No unique moat types yet.
Roche Holding AG strengths
Segment mix
Abbott Laboratories segments
Full profile >Established Pharmaceutical Products
Competitive
Pediatric Nutrition
Oligopoly
Adult Nutrition
Oligopoly
Core Laboratory Diagnostics
Oligopoly
Rapid and Molecular Diagnostics
Competitive
Cancer Diagnostics
Competitive
Diabetes Care (CGM and glucose monitoring)
Oligopoly
Cardiovascular and Electrophysiology Devices
Oligopoly
Neuromodulation Devices
Oligopoly
Roche Holding AG segments
Full profile >Pharmaceuticals
Competitive
Diagnostics
Oligopoly
Act on this comparison
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.